• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过肠脑代谢分析研究大麻二酚对转基因小鼠模型帕金森病的影响。

Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis.

作者信息

Zhao Jinchuan, Gao Xin, Zhao Liangyou, Wang Yiqing, Zhang Jingbo, Liu Shumin

机构信息

Heilongjiang University of Chinese Medicine, Harbin, China.

Drug Safety Evaluation Center, Heilongjiang University of Chinese Medicine, Harbin, China.

出版信息

Evid Based Complement Alternat Med. 2022 Mar 22;2022:1525113. doi: 10.1155/2022/1525113. eCollection 2022.

DOI:10.1155/2022/1525113
PMID:35360659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8964161/
Abstract

Parkinson's disease (PD) is a common neurodegenerative disease characterized by a disorder of the dopaminergic system in the midbrain, causing classical PD motor symptoms. The therapeutic effect of cannabidiol (CBD) on PD has been a research frontier in recent years. However, the pathogenesis of PD and the therapeutic mechanism of cannabinoid remain unclear. To further study the causes of PD and the effect of CBD on PD, we exposed the PD transgenic mouse model to CBD and then estimated the motorial and postural coordination through a modified swim test. Afterwards, the mechanism was investigated via the histopathology of substantia nigra and the gut-brain metabolic analysis in the approach of UHPLC-TOF-MS. The results showed that CBD significantly improved motor deficits of PD model and protected the substantia nigra area. The metabolic function of fatty acid biosynthesis, arginine biosynthesis/metabolism, butanoate (ketone body) metabolism, -alanine metabolism, and pantothenate/CoA biosynthesis was highlighted in the pathological and therapeutic process along the gut-brain axis. In conclusion, CBD could attenuate PD via the neuroprotective effect on the midbrain. The attenuation of the central nervous system in turn improved motor performance of PD, which might be partially induced by the metabolic interaction between the gut-brain. In view of gut-brain metabolomics, the mechanism of PD pathogenesis and the effect of CBD on PD are highly related to the biosynthesis and metabolism of energy and essential substance.

摘要

帕金森病(PD)是一种常见的神经退行性疾病,其特征是中脑多巴胺能系统紊乱,导致典型的PD运动症状。近年来,大麻二酚(CBD)对PD的治疗作用一直是研究前沿。然而,PD的发病机制和大麻素的治疗机制仍不清楚。为了进一步研究PD的病因以及CBD对PD的影响,我们将PD转基因小鼠模型暴露于CBD中,然后通过改良的游泳试验评估其运动和姿势协调性。之后,通过黑质组织病理学和UHPLC-TOF-MS方法进行肠-脑代谢分析来研究其机制。结果表明,CBD显著改善了PD模型的运动缺陷并保护了黑质区域。在沿肠-脑轴的病理和治疗过程中,脂肪酸生物合成、精氨酸生物合成/代谢、丁酸(酮体)代谢、β-丙氨酸代谢以及泛酸/辅酶A生物合成的代谢功能得到了突出体现。总之,CBD可通过对中脑的神经保护作用减轻PD。中枢神经系统的减轻进而改善了PD的运动表现,这可能部分是由肠-脑之间的代谢相互作用诱导的。从肠-脑代谢组学的角度来看,PD发病机制以及CBD对PD的影响机制与能量和必需物质的生物合成及代谢高度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/ae41db0f219a/ECAM2022-1525113.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/5aa253b6d50d/ECAM2022-1525113.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/f9555d4f8754/ECAM2022-1525113.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/2b26b9dbc443/ECAM2022-1525113.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/ae41db0f219a/ECAM2022-1525113.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/5aa253b6d50d/ECAM2022-1525113.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/f9555d4f8754/ECAM2022-1525113.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/2b26b9dbc443/ECAM2022-1525113.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c12/8964161/ae41db0f219a/ECAM2022-1525113.004.jpg

相似文献

1
Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis.通过肠脑代谢分析研究大麻二酚对转基因小鼠模型帕金森病的影响。
Evid Based Complement Alternat Med. 2022 Mar 22;2022:1525113. doi: 10.1155/2022/1525113. eCollection 2022.
2
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?大麻二酚是否是治疗非运动性帕金森病症状的理想药物?
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):121-133. doi: 10.1007/s00406-019-00982-6. Epub 2019 Jan 31.
3
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.大麻二酚对帕金森病动物模型的神经保护和症状缓解作用。
Int J Mol Sci. 2021 Aug 18;22(16):8920. doi: 10.3390/ijms22168920.
4
GPR55: A therapeutic target for Parkinson's disease?GPR55:帕金森病的治疗靶点?
Neuropharmacology. 2017 Oct;125:319-332. doi: 10.1016/j.neuropharm.2017.08.017. Epub 2017 Aug 12.
5
Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway.大麻二酚在帕金森病体外模型中通过激活 AKT/mTOR 通路发挥保护作用。
Fitoterapia. 2020 Jun;143:104553. doi: 10.1016/j.fitote.2020.104553. Epub 2020 Mar 14.
6
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease.大麻二酚作为一种治疗靶点:其在帕金森病中神经保护和神经调节功能的证据
Front Pharmacol. 2020 Dec 15;11:595635. doi: 10.3389/fphar.2020.595635. eCollection 2020.
7
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.T 细胞驱动的炎症作为涉及帕金森病的肠道-大脑轴的中介。
Front Immunol. 2019 Feb 15;10:239. doi: 10.3389/fimmu.2019.00239. eCollection 2019.
8
Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.粪便微生物群移植通过抑制脂多糖-TLR4 信号通路介导的炎症反应,经由肠道菌群-肠-脑轴保护鱼藤酮诱导的帕金森病小鼠。
Microbiome. 2021 Nov 17;9(1):226. doi: 10.1186/s40168-021-01107-9.
9
Biological bases for a possible effect of cannabidiol in Parkinson's disease.大麻二酚在帕金森病中可能产生作用的生物学基础。
Braz J Psychiatry. 2020 Apr;42(2):218-224. doi: 10.1590/1516-4446-2019-0460. Epub 2019 Jul 15.
10
Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.大麻二酚通过靶向 WNT/β-连环蛋白通路、氧化应激和炎症在帕金森病中的潜在作用。
Aging (Albany NY). 2021 Apr 13;13(7):10796-10813. doi: 10.18632/aging.202951.

引用本文的文献

1
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson's and Alzheimer's Disease.植物大麻素在神经退行性疾病中的最新临床前证据:聚焦帕金森病和阿尔茨海默病
Pharmaceuticals (Basel). 2025 Jun 13;18(6):890. doi: 10.3390/ph18060890.
2
Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism.大麻二酚在利血平诱导的帕金森病进行性模型中的预防性有益作用。
Front Pharmacol. 2025 May 8;16:1539783. doi: 10.3389/fphar.2025.1539783. eCollection 2025.
3
Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson's Disease Rat Model.

本文引用的文献

1
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.大麻二酚对帕金森病动物模型的神经保护和症状缓解作用。
Int J Mol Sci. 2021 Aug 18;22(16):8920. doi: 10.3390/ijms22168920.
2
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease.大麻二酚作为一种治疗靶点:其在帕金森病中神经保护和神经调节功能的证据
Front Pharmacol. 2020 Dec 15;11:595635. doi: 10.3389/fphar.2020.595635. eCollection 2020.
3
Four main therapeutic keys for Parkinson's disease: A mini review.
大脑区域特异性蛋白瓜氨酸化/脱亚胺化在运动前期帕金森病大鼠模型中的差异。
Int J Mol Sci. 2024 Oct 17;25(20):11168. doi: 10.3390/ijms252011168.
4
Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease.内源性大麻素系统调节剂在帕金森病中的治疗应用。
Int J Mol Sci. 2024 Aug 5;25(15):8520. doi: 10.3390/ijms25158520.
5
Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases.大麻素在神经退行性疾病中调节中枢和外周免疫的作用。
Int J Mol Sci. 2024 Jun 10;25(12):6402. doi: 10.3390/ijms25126402.
6
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.一篇关于大麻二酚治疗和补救前景的叙述性综述,重点关注神经和神经精神疾病。
J Cannabis Res. 2024 Mar 18;6(1):14. doi: 10.1186/s42238-024-00222-2.
7
Intervertebral disc degeneration and how it leads to low back pain.椎间盘退变及其如何导致腰痛。
JOR Spine. 2022 Nov 14;6(1):e1231. doi: 10.1002/jsp2.1231. eCollection 2023 Mar.
8
An update on animal models of intervertebral disc degeneration and low back pain: Exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics.椎间盘退变和腰痛动物模型的最新进展:探索人工智能在改善前瞻性治疗研究分析与开发方面的潜力。
JOR Spine. 2023 Jan 30;6(1):e1230. doi: 10.1002/jsp2.1230. eCollection 2023 Mar.
9
Effects of cannabinoids in Parkinson's disease animal models: a systematic review and meta-analysis.大麻素在帕金森病动物模型中的作用:一项系统评价和荟萃分析。
BMJ Open Sci. 2022 Dec 19;6(1):e100302. doi: 10.1136/bmjos-2022-100302. eCollection 2022.
10
Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids.肠道微生物群对肠-脑、肠-骨轴的调节作用以及大麻素的影响
Metabolites. 2022 Dec 10;12(12):1247. doi: 10.3390/metabo12121247.
帕金森病的四大主要治疗关键:一篇小型综述。
Iran J Basic Med Sci. 2019 Jul;22(7):716-721. doi: 10.22038/ijbms.2019.33659.8025.
4
Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.医用大麻作为帕金森病的替代疗法:系统评价。
Complement Ther Clin Pract. 2020 May;39:101154. doi: 10.1016/j.ctcp.2020.101154. Epub 2020 Mar 31.
5
Cannabidiol in Parkinson's disease.帕金森病中的大麻二酚
Braz J Psychiatry. 2020 Apr;42(2):126-127. doi: 10.1590/1516-4446-2019-0810. Epub 2020 Mar 16.
6
Cannabinoids, Blood-Brain Barrier, and Brain Disposition.大麻素、血脑屏障与脑内分布
Pharmaceutics. 2020 Mar 15;12(3):265. doi: 10.3390/pharmaceutics12030265.
7
Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.帕金森病:肠道微生物群失调、抗生素、益生菌及粪便微生物群移植的新作用
J Neurogastroenterol Motil. 2019 Jul 1;25(3):363-376. doi: 10.5056/jnm19044.
8
Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.基于代谢组学的帕金森病研究的最新进展和展望。
Mol Neurodegener. 2019 Jan 11;14(1):3. doi: 10.1186/s13024-018-0304-2.
9
Metabolomics Reveals that Crossbred Dairy Buffaloes Are More Thermotolerant than Holstein Cows under Chronic Heat Stress.代谢组学揭示,在慢性热应激下,杂交奶牛比荷斯坦奶牛更耐热。
J Agric Food Chem. 2018 Dec 12;66(49):12889-12897. doi: 10.1021/acs.jafc.8b02862. Epub 2018 Nov 30.
10
Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury.帕金森病与创伤性脑损伤在血液中的潜在代谢组学关联。
Metabolites. 2018 Sep 7;8(3):50. doi: 10.3390/metabo8030050.